(Q42545841)

2 November 2017

Metronomic chemotherapy with cyclophosphamide and dexamethasone in patients with metastatic carcinoma of the prostate (English)

1 reference

2 November 2017

1 reference

1 reference

P D Dickinson

1

1 reference

2 November 2017

D N Y Peel

series ordinal

2

1 reference

2 November 2017

S Sundar

series ordinal

3

1 reference

2 November 2017

language of work or name

English

0 references

publication date

13 March 2012

1 reference

British Journal of Cancer

2 November 2017

1 reference

2 November 2017

106

1 reference

2 November 2017

8

1 reference

2 November 2017

1464-5; author reply 1466

1 reference

Continuous low-dose cyclophosphamide and methotrexate combined with celecoxib for patients with advanced cancer

2 November 2017

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326681

Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: recommendations of the Prostate Cancer Clinical Trials Working Group

28 May 2018

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326681

Eligibility and response guidelines for phase II clinical trials in androgen-independent prostate cancer: recommendations from the Prostate-Specific Antigen Working Group.

28 May 2018

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326681

Metronomic therapy with cyclophosphamide and dexamethasone for prostate carcinoma

28 May 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22415241

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/BJC.2012.78

1 reference

2 November 2017

1 reference

2 November 2017

PubMed publication ID

22415241

1 reference